Showing results (1061-1070 of 1,683) with videos related to
Sort By:
Pageof 169
Frontiers in Microbiology|May 7, 2024
Role of N-acetylkynurenine in mediating the effect of gut microbiota on urinary tract infection: a Mendelian randomization studyYining He, Chao Han, Chengjuan Li, et al.Food Research International (Ottawa, Ont.)|December 6, 2025
Biophysical cues of edible microcarrier scaffolds regulate muscle satellite cell behavior and nutrient deposition in Larimichthys croceaXuan Zhou, Hongwei Zheng, Ruiyi Zhai, et al.Heliyon|September 25, 2024
Fibroblast growth factor 20 ameliorates cardiac hypertrophy via activation ErbB2Yunjie Chen, Xuan Zhou, Xu Wang, et al.Heliyon|September 19, 2024
The hemostatic molecular mechanism of Sanguisorbae Radix's pharmacological active components based on HSA: Spectroscopic investigations, molecular docking and dynamics simulationFei Xu, YuQing Shen, ZhiQiang Pan, et al.Journal of Gastrointestinal Oncology|September 16, 2024
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacologyZiming Zhu, Yinbiao Zhang, Xinyue Zhang, et al.Heliyon|February 22, 2024
Use of the improved tug-of-war acupuncture for promoting cartilage repair by inducing macrophage polarization in knee osteoarthritisJun Yan, Suying Jiang, Junjie Ma, et al.Medicine|November 21, 2023
A practical nomogram included hyperlipidemia for predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinomaJing Wang, Xiangji Liu, Tao Mao, et al.Mediators of Inflammation|July 28, 2023
Vitronectin Destroyed Intestinal Epithelial Cell Differentiation through Activation of PDE4-Mediated Ferroptosis in Inflammatory Bowel DiseaseWenxu Pan, Li Xiang, Xinhua Liang, et al.Parasites & Vectors|September 3, 2023
Eimeria zuernii (Eimeriidae: Coccidia): mitochondrial genome and genetic diversity in the Chinese yakXuan Zhou, Zhao Wang, Pengchen Zhu, et al.Frontiers in Immunology|February 23, 2026
Tocilizumab combined with short-term high-dose glucocorticoids for rapid disease activity control and glucocorticoid reduction in adult-onset Still's disease: a single-center retrospective studyShi-Lei Zhong, Yan-Ping Lei, Li-Xuan Zhou, et al.Pageof 169